Skip to main content
Equibles

UBS Group AG

Position in VVOS — Vivos Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to VVOS Full portfolio

Position in VVOS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,815
+$4,782 QoQ
Shares Held
39,154
+254.5% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 22 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VVOS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. VVOS ranks #113 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in VVOS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,815 39,154
2026-03-31 $13,033 11,046
2025-12-31 $25,733 12,677
2025-09-30 $316 102
2025-06-30 $451,251 142,801
2025-03-31 $5,355 1,879
2024-12-31 $1,668 389
2024-09-30 $203 78
2023-09-30 $1,777 9,257
2022-12-31 $7,562 18,812
2022-09-30 $6,280 9,663
2022-06-30 $2,854 2,213
2021-12-31 $38,436 17,083
2021-09-30 $11,695 2,895
2021-06-30 $11,583 2,340
2021-03-31 $14,063 2,118